carcinoembryon
antigenrel
cell
adhes
molecul
also
known
biliari
multifunct
transmembran
protein
express
divers
cell
type
includ
epitheli
cell
certain
cell
immun
system
like
structur
relat
ceacam
protein
member
ig
superfamili
basic
structur
sequenti
order
iglik
domain
protein
serv
adhes
molecul
via
homophil
heterophil
interact
particip
multipl
physiolog
pathophysiolog
cell
cell
process
moreov
direct
immunomodulatori
consequ
suggest
base
immun
cell
express
presenc
itim
motif
intracellular
domain
protein
earli
experi
investig
tumorigenesi
denot
pivot
role
tumor
suppressor
exampl
prostat
cancer
cell
line
transfect
demonstr
significantli
lower
growth
rate
less
tumorigen
vivo
rel
control
nittka
et
al
found
absenc
hyperplast
tumor
correl
reduc
apoptosi
malign
cell
moreov
lack
wapt
tumor
cell
result
increas
wnt
signal
promot
cellular
invas
strongli
enhanc
rate
metastasi
mammari
adenocarcinoma
vivo
hand
investig
suggest
role
angiogenesi
suppress
neoantigenspecif
antitumor
respons
express
tumor
cell
implic
prognost
factor
differ
associ
observ
depend
tumor
type
stage
cancer
stabl
express
melanoma
cell
enhanc
invas
migrat
cell
vitro
reduc
express
report
upon
malign
transform
mice
sampl
human
colorect
cancer
similarli
express
invers
correl
surviv
breast
cancer
patient
frequent
loss
benign
malign
colorect
neoplasia
also
report
addit
thom
et
al
found
signific
posit
correl
express
primari
tumor
lymph
node
metastas
furthermor
express
primari
cutan
melanoma
lesion
link
develop
metastat
diseas
poor
prognosi
thu
biolog
appear
complex
dispar
pathophysiolog
effect
manifest
contextdepend
manner
increas
interest
oncolog
commun
explor
potenti
target
cancer
immunotherapi
given
express
tumor
immun
cell
potenti
immunomodulatori
properti
shown
recruit
complex
result
reduc
phosphoryl
consequ
decreas
activ
pathway
vitro
also
shown
modul
cell
activ
differenti
vivo
activ
inhibitori
effect
report
addit
regul
function
cell
act
critic
surviv
factor
b
cell
modul
cytolyt
function
nk
cell
major
cell
human
melanoma
sampl
report
coexpress
exhaust
murin
cell
induct
toler
tumor
implant
defici
mice
exhibit
impair
growth
rate
mous
ab
prevent
tumor
growth
combin
mab
data
led
propos
play
role
immun
checkpoint
similar
block
product
antitumor
respons
vivo
light
conflict
partial
oppos
observ
regard
role
antitumor
respons
endeavor
character
express
combin
evalu
potenti
tumor
growth
modul
properti
use
anti
ceacam
mab
antimous
ab
wide
use
preclin
studi
evalu
biolog
vitro
vivo
sever
studi
demonstr
immunomodulatori
properti
vivo
perform
use
mab
initi
gener
immun
sjlj
mice
purifi
balbc
intestin
brush
border
membran
subsequ
purifi
hybridoma
deriv
fusion
cell
spleen
cell
immun
mice
detail
function
character
ab
carri
multipl
studi
littl
inform
avail
bind
characterist
vitro
moreov
data
report
regard
pharmacokinet
properti
tumor
bear
cancer
model
present
studi
sought
character
express
profil
effect
ab
syngen
mous
tumor
model
vivo
delin
potenti
mechan
blockad
antitumor
therapi
express
profil
surfac
tumor
infiltr
comprehens
assess
use
flow
cytometri
sever
mous
syngen
tumor
model
use
analys
avoid
tumor
typespecif
bia
subcutan
tumor
establish
day
post
implant
express
first
measur
untreat
tumor
flow
cytometri
figur
case
high
level
express
observ
granulocyt
monocyt
myeloid
cell
tumor
test
figur
shown
frequenc
cell
express
level
cell
low
next
investig
possibl
cell
could
upregul
blockad
upon
tcrmediat
stimul
within
tumor
microenviron
tumorbear
mice
treat
mab
isotyp
control
everi
four
day
two
dose
four
day
second
dose
tumor
harvest
dissoci
immunophenotyp
order
assess
chang
express
figur
averag
proport
cell
remain
less
total
cell
statist
signific
increas
frequenc
cell
two
dose
observ
figur
upper
panel
frequenc
cell
appear
variabl
differ
tumor
exampl
tumor
rel
higher
frequenc
cell
compar
nevertheless
frequenc
cell
remain
unchang
vivo
treatment
similarli
frequenc
popul
treg
myeloid
cell
chang
vivo
treatment
data
shown
evalu
potenti
block
ligand
interact
establish
protein
cellbas
elisa
assay
mous
interact
observ
protein
elisa
use
recombin
protein
cell
elisa
celisa
use
solubl
protein
mous
cell
line
figur
also
report
interact
therefor
aim
analyz
interact
celisa
use
recombin
mous
protein
mous
transfect
cell
line
assay
format
observ
direct
interact
express
confirm
use
mab
figur
also
attempt
analyz
potenti
interact
method
biacor
protein
elisa
use
human
recombin
protein
interact
two
protein
observ
assay
format
either
data
shown
blockad
interact
observ
either
protein
cellbas
elisa
figur
assay
unexpectedli
observ
increas
bind
signal
increas
concentr
figur
similar
result
obtain
flow
cytometri
data
shown
solubl
bind
transfect
cell
analyz
presenc
antibodi
data
suggest
antibodi
may
provid
bridg
effect
link
two
molecul
togeth
rather
block
homophil
interact
bridg
effect
occur
hypothes
twoarm
fulllength
igg
molecul
would
need
address
question
also
gener
fab
fragment
fab
use
assay
observ
increas
signal
increas
concentr
fab
instead
fab
block
homophil
interact
celisa
figur
protein
elisa
data
shown
undetect
bind
assay
potenti
effect
interact
studi
pk
properti
studi
balbc
mice
tabl
pk
paramet
nonlinear
mgkg
mgkg
significantli
overdos
proport
increas
cmax
signific
differ
clf
mgkg
exhibit
fast
clearanc
clf
mlhkg
concentr
drop
ugml
h
cmax
ugml
hr
post
dose
uncommon
pk
featur
mab
suggest
signific
sink
effect
mediat
targetassoci
drug
disposit
could
part
due
abund
express
myeloid
cell
includ
neutrophil
mgkg
clearanc
significantli
reduc
clf
mlhkg
mgkg
mgkg
resembl
profil
nontarget
interestingli
mgkg
dose
pk
linear
cmax
dose
proport
mgkg
mgkg
consequ
mgkg
dose
chosen
experi
tumor
model
moreov
simul
multidos
everi
day
pk
profil
mgkg
dose
show
trough
level
approxim
nm
expect
suffici
block
bind
vivo
inde
full
receptor
occup
cellular
level
vivo
treatment
mgkg
demonstr
flow
cytometri
stain
tumor
infiltr
use
fluorescencelabel
monotherapi
group
combin
therapi
group
fluorescencelabel
abl
stain
target
receptor
stain
cell
shown
figur
complet
block
consist
mice
monotherapi
combin
therapi
group
figur
find
confirm
treatment
fulli
engag
tumor
infiltr
dose
level
mgkg
studi
impact
dose
level
mgkg
use
mani
syngen
mous
tumor
model
good
efficaci
exposur
profil
impact
alon
singl
agent
studi
potenti
combin
effect
antibodi
util
three
subcutan
mous
tumor
model
colorect
bladder
b
cell
lymphoma
mgkg
treatment
without
mgkg
well
toler
effect
mous
bodi
weight
across
model
throughout
durat
studi
data
shown
experi
baselin
tumor
volum
control
group
random
differ
treatment
group
day
tumor
control
group
increas
approxim
figur
show
mgkg
ip
administ
everi
day
significantli
attenu
tumor
growth
rel
control
contrast
treatment
mgkg
ip
given
everi
day
inhibit
tumor
volum
day
approxim
modul
growth
curv
coadministr
mgkg
indic
observ
combin
benefit
model
similarli
obviou
combin
activ
demonstr
either
model
figur
assess
whether
intratumor
immun
activ
alter
follow
monotherapi
combin
treatment
tumor
infiltr
isol
model
multipl
paramet
analyz
absolut
number
treg
cell
ratio
treg
cell
frequenc
ico
cell
tumor
day
post
initi
dose
group
signific
increas
number
cell
treg
cell
found
tumor
mice
treat
combin
figur
effect
treatment
cellstreg
ratio
figur
previou
studi
demonstr
one
costimulatori
receptor
induc
costimul
ico
express
cell
immun
check
point
blockad
effect
qualit
assess
intratumor
cell
treatment
frequenc
icosexpress
cell
monitor
monotherapi
group
show
signific
expans
ico
cell
tumor
compar
isotyp
control
group
significantli
increas
ico
express
monotherapi
combin
figur
addit
consist
chang
proport
nk
cell
b
cell
monocyt
dendrit
cell
myeloidderiv
suppressor
cell
myeloid
granulocyt
upon
treatment
observ
data
shown
pleiotrop
cell
surfac
molecul
express
divers
cell
type
express
level
rapidli
modul
upon
activ
ad
complex
defin
unambigu
role
health
diseas
current
studi
evalu
potenti
block
ligand
interact
studi
express
til
syngen
tumor
model
defin
pk
characterist
ip
administr
profil
antitumor
effect
syngen
mous
model
found
express
rel
high
level
freshli
harvest
tumor
infiltr
b
nk
cell
mdsc
although
proport
cell
low
addit
present
result
demonstr
low
express
tumor
infiltr
cell
across
three
differ
tumor
model
find
diverg
previous
publish
observ
identifi
marker
exhaust
cell
tumor
microenviron
major
cell
human
melanoma
sampl
express
ihc
mice
signific
fraction
tumor
infiltr
cell
also
report
express
reason
appar
differ
tumor
express
profil
studi
other
unclear
differ
tumor
microenviron
stain
condit
rule
appear
unlik
due
strong
stain
observ
myeloid
cell
tumor
cell
use
us
other
immun
checkpoint
inhibitor
mab
demonstr
remark
clinic
benefit
multipl
cancer
type
given
express
immun
cell
tumor
cell
report
upregul
follow
activ
tumor
cell
contact
also
investig
whether
treatment
enhanc
express
cell
express
tumor
infiltr
cell
remain
low
whether
anim
treat
multipl
dose
level
provid
strong
antitumor
activ
vivo
data
suggest
low
impact
direct
regul
tumor
infiltr
cell
antimous
ab
use
number
preclin
studi
evalu
potenti
antitumor
target
howev
abl
find
publish
studi
describ
ligand
block
capac
antibodi
therefor
establish
protein
cellbas
elisa
assay
evalu
impact
homophil
interact
unexpectedli
inclus
mab
assay
enhanc
signal
result
interact
suggest
enhanc
rather
block
interact
data
also
appear
indic
ab
abl
bind
two
molecul
simultan
consequ
establish
bridg
relationship
bridg
effect
occur
appear
twoarm
fulllength
igg
molecul
need
conclus
support
result
show
fab
fragment
increas
signal
homophil
bind
assay
addit
studi
need
fulli
evalu
function
signific
bind
profil
also
report
interact
thu
studi
potenti
effect
interact
howev
unabl
reproduc
detect
bind
henc
evalu
assay
feasibl
minim
bind
observ
cellbas
assay
use
mous
reagent
figur
proteinbas
assay
use
human
reagent
data
shown
sinc
interact
shown
occur
ci
membran
distal
ntermin
domain
molecul
tran
ntermin
domain
develop
addit
assay
assess
potenti
effect
interact
need
current
data
reveal
reason
lack
detect
bind
assay
low
affin
interact
like
play
role
addit
identifi
anoth
ligand
ubiquit
express
multipl
tissu
cell
type
potenti
interfer
cellbas
assay
rule
howev
note
prior
studi
suggest
modul
interact
ab
previou
studi
provid
function
evid
tumor
growth
modul
activ
reduc
growth
tumor
cell
observ
defici
mice
addit
treatment
ab
combin
blockad
result
robust
tumor
growth
inhibit
increas
tumor
infiltr
cell
model
one
limit
prior
studi
report
pharmacokinet
characterist
level
target
engag
achiev
experi
experi
found
rel
short
mice
associ
rapid
clearanc
part
may
relat
high
express
myeloid
cell
facilit
receptormedi
deposit
vivo
syngen
tumor
model
ab
administ
singl
agent
therapi
combin
mab
provid
tumor
growth
inhibit
import
point
full
target
engag
achiev
vivo
experi
base
tumor
immunophenotyp
experi
show
greater
suppress
cell
surfac
stain
anim
fact
maintain
plasma
trough
level
well
receptor
bind
dose
mgkg
next
studi
possibl
ab
modul
phenotyp
tumor
infiltr
immun
cell
flow
cytometri
analysi
tumorinfiltr
cell
freshli
isol
syngen
tumor
reveal
chang
proport
cell
treg
cell
nk
cell
b
cell
monocyt
dendrit
cell
myeloidderiv
suppressor
cell
myeloid
granulocyt
upon
treatment
addit
phenotyp
chang
observ
tumor
infiltr
cell
deriv
mice
treat
monotherapi
combin
ab
taken
togeth
present
studi
demonstr
low
express
tumor
infiltr
mous
cell
signific
express
observ
b
cell
nk
cell
mdsc
express
profil
similar
observ
freshli
isol
human
tumor
lee
et
al
manuscript
preparationsubmit
evalu
potenti
role
antitumor
respons
syngen
tumor
model
use
mab
reveal
antitumor
benefit
mab
monotherapi
combin
mab
howev
ab
wide
use
prior
vivo
studi
data
suggest
mab
facilit
rather
block
interact
therefor
studi
use
block
ab
requir
thoroughli
understand
role
tumorigenesi
antitumor
respons
vivo
potenti
role
b
cell
nk
cell
mdsc
address
studi
focu
futur
studi
low
minim
express
tumor
infiltr
cell
suggest
primari
function
vivo
mediat
via
cell
cell
potenti
role
immunooncolog
remain
establish
evalu
homophil
interact
interact
perform
protein
elisa
cell
elisa
celisa
celisa
microtit
plate
seed
transfect
cho
cell
day
prior
assay
day
cell
confluent
assay
day
cell
cultur
supernat
aspir
serial
dilut
mceacamhfc
sino
biolog
control
protein
hfc
ad
microtit
plate
dilut
done
cell
cultur
medium
dmem
gibco
supplement
fetal
bovin
serum
minut
incub
room
temperatur
plate
wash
three
time
wash
buffer
pb
contain
tween
afterward
horseradish
peroxidaseconjug
goat
antihuman
igg
jackson
immunoresearch
dilut
cell
cultur
medium
ad
incub
room
temperatur
min
final
plate
wash
five
time
nitro
tmbelisa
substrat
thermofisch
per
well
ad
min
reaction
stop
ad
tmb
stop
solut
kpl
absorb
measur
nm
protein
elisa
perform
similar
celisa
differ
protein
elisa
microtit
plate
coat
mceacamhi
sino
biolog
pb
c
overnight
next
day
plate
wash
three
time
wash
buffer
block
supeblock
thermo
scientif
one
hour
room
temperatur
wash
plate
addit
control
hfc
addit
antihuman
hrp
incub
step
celisa
final
plate
wash
five
time
abt
peroxidas
substrat
kpl
per
well
ad
min
absorb
measur
nm
evalu
effect
antibodi
homophil
interact
elisa
celisa
assay
use
similar
describ
modif
elisa
coat
block
perform
way
afterward
serial
dilut
solut
antibodi
start
isotyp
control
ad
microtit
plate
min
incub
room
temperatur
ul
mceacamhfc
sino
biolog
ml
ad
incub
anoth
min
next
plate
wash
three
time
wash
buffer
bound
detect
use
horseradish
peroxidaseconjug
goat
antihuman
igg
jackson
immunoresearch
describ
celisa
similar
protocol
use
except
use
step
perform
way
elisa
assay
vivo
studi
perform
accord
guidelin
institut
laboratori
anim
research
ilar
studi
part
institut
anim
care
use
committe
iacuc
approv
protocol
anim
hous
aaalac
intern
accredit
research
facil
sinc
experiment
key
readout
termin
studi
anim
group
use
euthan
end
studi
femal
balbc
mice
week
old
micegroup
dose
intraperiton
ip
mgkg
mgkg
mgkg
previou
describ
serial
microsampl
method
use
obtain
plasma
mous
hour
follow
dose
plasma
concentr
determin
electrochemiluminesc
ecl
method
briefli
recombin
mous
sinobiolog
use
captur
reagent
sulfotag
affinipur
goat
antimous
igg
use
detect
reagent
twentyf
microlit
captur
reagent
ad
well
small
spot
plate
meso
scale
discoveri
incub
overnight
c
shake
wash
pb
three
time
plate
block
bovin
serum
albumin
bsa
per
well
incub
room
temperatur
hour
shake
addit
wash
twentyf
calibr
standard
qualiti
control
sampl
ad
well
wash
plate
incub
room
temperatur
hour
shake
wash
plate
incub
sulfotag
affinipur
goat
antimous
igg
hour
room
temperatur
plate
wash
three
time
read
buffer
meso
scale
discoveri
ad
well
plate
follow
read
meso
sector
model
meso
scale
discoveri
concentr
data
analyz
key
pk
paramet
calcul
use
noncompartment
method
softwar
data
also
analyz
compartment
model
use
simul
multidos
pk
profil
tumor
cell
clone
nnitrosonmethylurethan
nnmu
induc
undifferenti
colon
carcinoma
cell
line
initi
primari
n
formamid
fanft
induc
murin
bladder
tumor
aris
mice
cell
cultur
dmem
medium
respect
contain
fetal
bovin
serum
mous
colon
adenocarcinoma
celllin
mous
bladder
carcinoma
celllin
cultur
dmem
medium
fetal
bovin
serum
tumor
cell
grown
tissu
cultur
flask
humidifi
incub
atmospher
condit
air
cell
line
balbc
b
cell
lymphoma
line
deriv
spontan
reticulum
cell
neoplasm
cell
cultur
medium
contain
fetal
bovin
serum
mm
tissu
cultur
flask
describ
eight
week
old
femal
balbc
mice
purchas
tacon
new
york
ny
usa
tumor
efficaci
studi
conduct
three
differ
syngen
mous
model
name
colon
carcinoma
bladder
b
cell
lymphoma
model
balbc
mice
inocul
subcutan
right
lower
flank
cell
experi
mice
inject
cell
lower
right
flank
tumor
measur
calib
two
time
per
week
tumor
volum
determin
use
relationship
volum
length
mice
euthan
tumor
reach
volum
random
mice
treatment
group
occur
mean
tumor
volum
reach
approxim
examin
increas
dose
level
mgkg
ip
qd
everi
day
tumor
growth
model
addit
studi
effect
treatment
alon
mgkg
ip
qd
everi
two
day
combin
mgkg
murin
version
surrog
antimous
mab
qd
everi
day
model
vehicl
control
receiv
mous
antibodi
vehicl
dose
chosen
base
demonstr
efficaci
achiev
syngen
mous
tumor
model
immunophenotyp
tumor
cell
model
conduct
flow
cytometri
tumor
cell
excis
indic
time
point
minc
mechan
digest
subject
enzymat
digest
use
gentlemac
mous
tumor
digest
kit
per
manufactur
instruct
miltenyi
biotec
follow
digest
singl
cell
suspens
obtain
filtrat
multipl
wash
absolut
live
cell
count
determin
use
chemometec
nucleocount
cell
suspens
stain
fixabl
livedead
stain
life
technolog
wash
expos
mous
fcblok
bd
bioscienc
immun
cell
profil
conduct
use
antimous
antibodi
clone
purchas
either
bd
bioscienc
biolegend
ebiosciencethermo
iaie
clone
intracellular
stain
cell
permeabil
use
factor
stain
buffer
set
incub
antimous
helio
ebiosci
stain
cell
fix
formaldehyd
wash
pb
store
c
analysi
bd
lsrfortessa
bd
bioscienc
data
analysi
perform
use
fc
express
de
novo
softwar
flowjo
flowjo
llc
mice
per
treatment
group
includ
flow
cytometri
analys
immun
subset
discrimin
determin
gate
live
cell
leukocyt
gate
fsc
vs
ssc
size
discrimin
via
follow
gate
scheme
cell
treg
cell
gate
gmdsc
mmdsc
cdc
pdc
macrophag
monocyt
b
cell
nklike
cell
popul
minimum
event
acquir
